Optimal Attained LDL-Cholesterol Levels in Patients Who Achieved ≥50% LDL Reduction After PCI

CompletedOBSERVATIONAL

Enrollment

135,877

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

May 15, 2025

Conditions

Coronary Artery DiseaseHyperlipidemias

Interventions

DRUG

LDL reduction therapy

Trial Locations (1)

Samsung Medical Center, Seoul

All Listed Sponsors

lead

Samsung Medical Center

OTHER

NCT06338956 - Optimal Attained LDL-Cholesterol Levels in Patients Who Achieved ≥50% LDL Reduction After PCI | Biotech Hunter | Biotech Hunter